Mylan

AbbVie signs patent licensing deal with Mylan over Humira biosimilar

AbbVie has entered patent licence agreements with Mylan for the proposed biosimilar product of its Humira (adalimumab) drug. Adalimumab is…

Mylan launches generic version of Novartis’ Exelon Patch

Mylan has launched Rivastigmine Transdermal System, a generic version of Novartis' Exelon Patch, for the treatment of patients suffering from…